Dexcom Inc Stock Market Value

DXCM Stock  USD 130.71  3.59  2.67%   
DexCom's market value is the price at which a share of DexCom trades on a public exchange. It measures the collective expectations of DexCom Inc investors about its performance. DexCom is selling at 130.71 as of the 19th of April 2024; that is -2.67 percent decrease since the beginning of the trading day. The stock's lowest day price was 129.17.
With this module, you can estimate the performance of a buy and hold strategy of DexCom Inc and determine expected loss or profit from investing in DexCom over a given investment horizon. Check out DexCom Correlation, DexCom Volatility and DexCom Alpha and Beta module to complement your research on DexCom.
Symbol

DexCom Inc Price To Book Ratio

Is DexCom's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.81
Earnings Share
1.3
Revenue Per Share
9.384
Quarterly Revenue Growth
0.269
Return On Assets
0.0641
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

DexCom 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DexCom's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DexCom.
0.00
03/20/2024
No Change 0.00  0.0 
In 31 days
04/19/2024
0.00
If you would invest  0.00  in DexCom on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding DexCom Inc or generate 0.0% return on investment in DexCom over 30 days. DexCom is related to or competes with Agilent Technologies, Illumina, Waters, Thermo Fisher, Mettler Toledo, Charles River, and Guardant Health. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ... More

DexCom Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DexCom's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DexCom Inc upside and downside potential and time the market with a certain degree of confidence.

DexCom Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DexCom's standard deviation. In reality, there are many statistical measures that can use DexCom historical prices to predict the future DexCom's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of DexCom's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
132.06134.34136.62
Details
Intrinsic
Valuation
LowRealHigh
128.67130.95147.73
Details
Naive
Forecast
LowNextHigh
132.79135.08137.36
Details
24 Analysts
Consensus
LowTargetHigh
124.67137.00152.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as DexCom. Your research has to be compared to or analyzed against DexCom's peers to derive any actionable benefits. When done correctly, DexCom's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in DexCom Inc.

DexCom Inc Backtested Returns

We consider DexCom very steady. DexCom Inc secures Sharpe Ratio (or Efficiency) of 0.0379, which denotes the company had a 0.0379% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for DexCom Inc, which you can use to evaluate the volatility of the firm. Please confirm DexCom's Mean Deviation of 1.49, coefficient of variation of 1599.51, and Downside Deviation of 1.74 to check if the risk estimate we provide is consistent with the expected return of 0.0865%. DexCom has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.07, which means a somewhat significant risk relative to the market. DexCom returns are very sensitive to returns on the market. As the market goes up or down, DexCom is expected to follow. DexCom Inc right now shows a risk of 2.28%. Please confirm DexCom Inc skewness, and the relationship between the potential upside and rate of daily change , to decide if DexCom Inc will be following its price patterns.

Auto-correlation

    
  0.32  

Below average predictability

DexCom Inc has below average predictability. Overlapping area represents the amount of predictability between DexCom time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom Inc price movement. The serial correlation of 0.32 indicates that nearly 32.0% of current DexCom price fluctuation can be explain by its past prices.
Correlation Coefficient0.32
Spearman Rank Test0.25
Residual Average0.0
Price Variance7.23

DexCom Inc lagged returns against current returns

Autocorrelation, which is DexCom stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DexCom's stock expected returns. We can calculate the autocorrelation of DexCom returns to help us make a trade decision. For example, suppose you find that DexCom has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

DexCom regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DexCom stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DexCom stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DexCom stock over time.
   Current vs Lagged Prices   
       Timeline  

DexCom Lagged Returns

When evaluating DexCom's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DexCom stock have on its future price. DexCom autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DexCom autocorrelation shows the relationship between DexCom stock current value and its past values and can show if there is a momentum factor associated with investing in DexCom Inc.
   Regressed Prices   
       Timeline  

Pair Trading with DexCom

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DexCom position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DexCom will appreciate offsetting losses from the drop in the long position's value.

Moving against DexCom Stock

  0.66TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.64IVP Inspire VeterinaryPairCorr
  0.59EMBC Embecta Corp Financial Report 10th of May 2024 PairCorr
  0.54AHG Akso Health GroupPairCorr
  0.47DYNT Dynatronics Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to DexCom could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DexCom when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DexCom - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DexCom Inc to buy it.
The correlation of DexCom is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DexCom moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DexCom Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DexCom can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:
Check out DexCom Correlation, DexCom Volatility and DexCom Alpha and Beta module to complement your research on DexCom.
Note that the DexCom Inc information on this page should be used as a complementary analysis to other DexCom's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for DexCom Stock analysis

When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
DexCom technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of DexCom technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of DexCom trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...